Vifor Pharma Deutschland GmbH, based in Munich, is a sales company and sole subsidiary of Vifor Pharma Participations AG (Switzerland) within the CSL group. The company conducts domestic distribution of group pharmaceuticals, primarily ferrocarboxymaltose products (e.g., Ferinject®, Feryxa®), as well as Venofer® and Ferrum Hausmann®. Core tasks are medical support, marketing and sales of group products in Germany. In the reporting year the company recorded revenues of TEUR 88,706 (net sales with third parties TEUR 64,419) and an EBIT of TEUR 4,608 (EBIT margin 7.15% on net sales with third parties); it is classified as a low-risk distributor and participates in group cash-pooling (cash fund at 30 June 2024: TEUR -3,489).
Handel mit pharmazeutischen und medizinischen Produkten aller Art.
This summary was generated with the help of AI. See our Data Quality Notice. Report error?
Source: German Commercial Register (Handelsregister) München Local Court, HRB 165582 (as of 30 August 2026)
Source: German Commercial Register (Handelsregister) München Local Court, HRB 165582 (as of 30 August 2026)
Sign in to download data
Source: German Commercial Register (Handelsregister) München Local Court, HRB 165582 (as of 30 August 2026)
Sign in to view detailed salary and cost trends.
